Inventor
Lakshmi Bhagat
Inventor
Framingham, MA, US
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes25%
C07HSugars18%
C12NMicroorganisms or enzymes17%
Y02ATechnologies for adaptation to climate change6%
A01NPreservation of bodies of humans or animals or plants or parts thereof2%
C07KPeptides2%
PatentTitleYear
9,453,228'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response'20169,206,430'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response'20158,946,175'Stabilized immunomodulatory oligonucleotides'20158,853,375'Toll like receptor modulators'20148,431,544'Compositions for inhibiting gene expression and uses thereof'20138,426,375'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response'20138,399,423'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response'20138,383,598'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response'20138,377,898'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response'20138,362,233'Stabilized immune modulatory RNA (SIMRA) compounds'20138,361,986'Synthetic agonists of TLR9'20138,357,665'Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response'20138,202,850'Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends'20128,188,261'Stabilized immune modulatory RNA (SIMRA) compounds'20128,153,605'Modulation of toll-like receptor 3 expression by antisense oligonucleotides'20128,153,608'Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides'20128,153,777'Modulation of toll-like receptor 5 expression by antisense oligonucleotides'20128,008,267'Stabilized immunomodulatory oligonucleotides'20117,960,362'Synthetic agonists of TLR9'20117,884,197'Synthetic agonists of TLR9'20117,875,594'Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents'20117,863,250'Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides'20117,851,453'Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides'20107,851,454'Short immunomodulatory oligonucleotides'20107,812,000'Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends'20107,749,975'Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends'20107,632,822'Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides'20097,595,305'Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides'20097,569,554'Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents'20097,517,862'Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends'20097,407,944'Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends'20087,354,907'Short immunomodulatory oligonucleotides'20087,276,489'Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2016Patents assigned to IDERA PHARMACEUTICALS INC (31)· patent assignee history
2007–2013Based in Brookline, MA, US· patent location history
2009–2016Based in Framingham, MA, US· patent location history
2012–2015Patents assigned to AGRAWAL SUDHIR (15)· patent assignee history
2012–2015Patents assigned to BHAGAT LAKSHMI (15)· patent assignee history
2012–2014Patents assigned to WANG DAQING (12)· patent assignee history
2012–2015Patents assigned to YU DONG (12)· patent assignee history
2015Based in Cambridge, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IDERA PHARMACEUTICALS INC | 31 | 2007–2016 |
| AGRAWAL SUDHIR | 15 | 2012–2015 |
| BHAGAT LAKSHMIself | 15 | 2012–2015 |
| WANG DAQING | 12 | 2012–2014 |
| YU DONG | 12 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Framingham, Massachusetts, US | 22 | 2009–2016 |
| Brookline, Massachusetts, US | 10 | 2007–2013 |
| Cambridge, Massachusetts, US | 1 | 2015 |